SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Mouse MAb
Cat: 40588-MM123
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Mouse MAb General Information
Product name
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Mouse MAb
Validated applications
WB,ELISA,ELISA(Cap)
Application notes
IHC, FCM, IF, IP et al. applications haven't been validated.
(Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
Specificity
SARS-CoV-2 Coronavirus Nucleocapsid
Has minimal cross-reactivity in WB and ELISA with
SARS-CoV NP Protein (Cat#40143-V08B)
No cross-reactivity in ELISA with
MERS-CoV NP Protein (Cat# 40068-V08B)
HCoV-229E NP Protein (Cat# 40640-V07E)
HCoV-NL63 NP Protein (Cat# 40641-V07E)
HCoV-HKU1 NP Protein (Cat# 40642-V07E)
HCoV-OC43 NP Protein (Cat# 40643-V07E)
Has minimal cross-reactivity in WB and ELISA with
SARS-CoV NP Protein (Cat#40143-V08B)
No cross-reactivity in ELISA with
MERS-CoV NP Protein (Cat# 40068-V08B)
HCoV-229E NP Protein (Cat# 40640-V07E)
HCoV-NL63 NP Protein (Cat# 40641-V07E)
HCoV-HKU1 NP Protein (Cat# 40642-V07E)
HCoV-OC43 NP Protein (Cat# 40643-V07E)
Immunogen
Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Catalog#40588-V08B)
Preparation
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, SARS-CoV-2 (2019-nCoV) Nucleocapsid (Catalog#40588-V08B; YP_009724397.2(335Gly/Ala); Met1-Ala419). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
Source
Monoclonal Mouse IgG1 Clone #123
Purification
Protein A
Formulation
0.2 μm filtered solution in PBS
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Mouse MAb Validated Applications
| Application | Dilution |
|---|---|
| WB | 1:1000-1:5000 |
| ELISA | 1:1000-1:2000 |
| ELISA(Cap) | 1:250-1:2000 |
Notes
| ELISA(Cap)： | In a sandwich ELISA, Cat# 40588-MM123 can be used as capture antibody when paired with Cat# 40588-R001, Cat# 40588-MM124. |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Mouse MAb Images
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid mouse monoclonal
antibody at 1:1000 dilution.
Lane A:SARS-CoV Nucleocapsid
Protein(Cat#40143-V08B) (30ng)
Lane B: SARS-CoV Nucleocapsid
Protein(Cat#40143-V08B) (10ng)
Lane C: SARS-CoV-2 (2019-nCoV) Nucleocapsid-His recombinant Protein(Cat#40588-V08B) (10ng)
Secondary
Goat Anti-Mouse IgG (H+L)/HRP at 1/10000 dilution.
Developed using the ECL technique.
Performed under reducing conditions.
Coronavirus Nucleocapsid Background Information
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. The coronavirus N protein is required for coronavirus RNA synthesis and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is the most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to the formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of the N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
References
- 1.Van Boheemen S, et al. (2012), MBio. 3(6):e00473-12.
- Bisht H. et al., 2004, Proc Natl Acad Sci. 101 (17): 6641-6.
- Li W. et al., 2005, Science. 309 (5742): 1864-8.
If you couldn't find the specific citation, you can:
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
